Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home
 
Publications
Quiniou G, Andromaque L, Duclaux-Loras R, Dinet O, Cervantes O, Verdet M, Meunier C, Boschetti G, Viret C, Nancey S, Faure M and Rozières A, Autophagy. 2024 Apr 14, doi: 10.1080/15548627.2024.2338574.
S.Wang, M.Prieux, S.de Bernard, M.Dubois, D.Laubreton , S.Djebali, M.Zala, C.Arpin, L.Genestier, Y.Leverrier, O.Gandrillon, F.Crauste, W.Jiang, J.Marvel
Trends in Microbiology; I. Dadole, D. Blaha, N. Personnic
Antiviral Res: Sinha D., Yaugel-Novoa M., Waeckel L., Paul S., Longet S. DOI: 10.1016/j.antiviral.2024.105823
R. Coudereau, G. Monneret, A-C. Lukaszewicz, B. F. Py, L. Argaud, M. Cour, F. Bidar, M. Gossez, F. Venet
Cui S, Xia T, Zhao J, Ren X, Wu T, Kameni M, Guo X, He L, Guo J, Duperray-Susini A, Levillayer F, Collard JM, Zhong J, Pan L, Tangy F, Vidalain PO, Zhou D, Jiu Y, Faure M, Wei Y. Nat Commun. 2023 Dec 19;14(1):8440. doi: 10.1038/s41467-023-44201-2. PMID: 38114531
 
News
On Wednesday January 24, 2024, Université Claude Bernard Lyon 1 (UCBL), Hospices Civils de Lyon (HCL) (HCL), the French National Research Agency (ANR) and Sanofi officially launched the the VIRESP industrial chair, a research project focusing on the development of techniques and tools for analyzing the risk of infection and the morbidity rate of diseases in different populations, but also to determine the benefits of vaccination programs.
On March 19, the local finale of Ma Thèse en 180 secondes will take place, with the 12 finalists. Among them, two are doing their PhD at the CIRI: Xanthe Adams-Ward (LegioPath) et Iris Dadole (Persist).
February 29, 2024 is Rare Disease Day. This is an opportunity to thank the clinicians and researchers who are advancing research on this subject at CIRI, as well as our patients!
The ARC Foundation brings together 5 leading cancer researchers for a 45-minute program. It will give the floor to experienced researchers and young talents, all ready to take up, together, the challenges of curing more patients.
Job offers
A 2-year post-doctoral position for a highly motivated and talented postdoctoral fellow is available in the team of Dr Marc Vocanson at the Centre International de Recherche en Infectiologie (CIRI), (...)
The IbIV team recruits a Data Manager, who will be responsible for gathering, organizing and validating all the data collected as part of a European project, focusing on COVID-19 and Long COVID.
Looking for a post-doctoral fellow in bacteriology/T6SS The I2BA team is recruiting a post-doctoral fellow to work on Francisella T6SS and its effectors (more details below).
EVIR Team: "Genetic reprogramming of B cells to enhance their therapeutic properties before autologous transfer"
Les thématiques de recherche associées à ce poste sont l'immunité muqueuse et la vaccinologie, celles de l'équipe GIMAP au sein de l'UMR CIRI. La personne recrutée participera aux enseignement (...)
The recruited person will carry out his or her research duties at the CIRI in the "Pathogenesis of Staphylococci" team. The recruitment is part of a wider effort to understand the impact of polymicrob (...)
The Inserm chair recruitments opened to Inserm are intended for researchers with strong potential to manage and lead research teams and participate in national, European or international projects. T (...)
Events
The NK/ILC symposium 2024 will take place at the amphithéatre Mérieux, Ecole Normale Supérieure, in Lyon, France on October 16-18, 2024.
The SFR Biosciences annual day will take place on Friday, June 7 2024 at the amphithéâtre Mérieux at the ENS. This year's theme is: Advanced data analysis for modern biology.
"Interferons as mediators of virally-triggered intestinal damage"
The annual congress of the French Virologie Society (SFV) will take place in Brussels (Belgium) in 2024!
The 2nd edition of BactoLyon will take place on April 11 2024, at the INSA, Villeurbanne.
“ DNA methylation and germinal center reaction: what Hells? ”